The largest database of trusted experimental protocols

Echo liquid handler

Manufactured by Beckman Coulter
Sourced in Ireland, United States

The Echo Liquid Handler is a non-contact liquid handling system that uses acoustic energy to aspirate and dispense precise volumes of liquids. It is designed to provide accurate, reliable, and reproducible liquid transfers across a range of applications in life science research.

Automatically generated - may contain errors

32 protocols using echo liquid handler

1

EPAC1-CNB and EPAC2-CNB Competitive Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Optimisation of 8-(2-[7-nitro-4-benzofurazanyl] aminoethylthio) adenosine-3′,5′-cyclic monophosphate (8-NBD-cAMP) competition assay was performed with purified EPAC1-CNB and EPAC2-CNB GST-fusion proteins, using modified assay conditions that were previously described21 (link). Optimisation of assay conditions was performed in 96 well black assay plates (Greiner). Comparison of reference molecules, dose response curves and pilot screen were done in black, low volume 384 assay plates (Greiner). Liquids were dispensed using a Biomek Fx laboratory automation workstation with a 96-multichannel pipetting head (Beckman Coulter) for optimisation, whereas the Echo® Liquid Handler (Labcyte) and Wellmate automated dispenser (Thermo Matrix) were employed for pilot screens (see library screening). Plates were incubated for four hours before 8-NBD-cAMP fluorescence intensity at 480/535 nm (ex/em) was measured using the Envision multi-label plate reader (Perkin-Elmer).
+ Open protocol
+ Expand
2

Quantifying Liver CYP Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from murine liver tissues using an RNeasy Mini Kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol. The concentration of RNA in each sample was quantified spectrophotometrically at 260 nm using a NanoPhotometer® N60 (Implen, Munich, Germany).
RNA was then transcribed to single-stranded cDNA using a Transcriptor High-Fidelity cDNA Synthesis Kit (Roche, Basel, Switzerland). The expression of CYPs and transcription factors was quantified by real-time qPCR performed in a LightCycler 1536 Instrument (Roche, Basel, Switzerland) using specific TaqMan Gene Expression Assays by Thermo Fisher Scientific (Life Technologies, Prague, Czech Republic) (see Supplemental Data). Miniaturized qPCR in 1536-well format plates were pipetted using Echo Liquid Handler (Labcyte, Dublin, Ireland). Calculations were based on the 2(-Delta Delta C(T)) method35 (link). The values of each target gene were normalized to the expression of the housekeeping gene - hypoxanthine guanine phosphoribosyl transferase (Hprt).
+ Open protocol
+ Expand
3

ROCK1 Enzyme Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human ROCK1 protein (amino acids 1–477 from accession number NP_05397.1) was purchased from Carna Biosciences (Cat# 01-109). This sequence contains the catalytic domain of the protein, and the biochemical activity was measured by the HTRF KinEASE-STK S2 Kit (Cisbio, Cat# 62ST2PEB) according to the manufacturer’s protocol. To determine the IC50, compounds were first dispensed by the Echo Liquid Handler (Labcyte) into white 384-well plates (PerkinElmer, Cat# 6008289). A total of 3 μL of 2x ROCK1 enzyme solution was added to the compounds, followed by a 10 min incubation at room temperature. Then, 2x ATP and STK S2 peptide solution were added to initiate the one-hour enzyme reaction at room temperature. The final condition of the reaction was 1.5 nM Rock1, 3 μM ATP, 0.5 μM STK S2 peptide in 50 mM HEPES pH7.2, 10 mM MgCl2, 0.1% BGG, 0.005% Brij-35, 1 mM DTT. The reaction was quenched by adding 6 μL of the detection mixture that contained Streptavidin XL665 and STK Antibody-Cryptate (Cisbio) and incubated for 1 hour at room temperature. The HTRF (665 nm/620 nm) signal was read on the PHERAstar reader (BMG Labtech). All measurements were done in triplicate.
+ Open protocol
+ Expand
4

LncRNA siRNA Screening Library Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Lincode siRNA Library (GE Dharmacon, G-301000) is a collection of siRNA reagents targeting 2231 human lncRNAs (1860 unique human lncRNA genes and 371 lncRNA transcripts associated with protein-coding genes). The design of this library is based on RefSeq version 54 and the siRNAs are arrayed as SMARTpools. The library was purchased at 0.1 nmol in a 96-well format. The library was diluted to a 5 μM stock with 1× siRNA buffer (GE Dharmacon, B-002000-UB-100) and arrayed onto black 384-well PerkinElmer Cell Carrier plates (Perkin Elmer, 6007550) using the Echo Liquid Handler (Labcyte). The black 384-well PerkinElmer Cell Carrier plates were prepared in advance and stored at −80 °C. The final siRNA concentration per well was 20 nM. An siRNA targeting exon 1 of lncRNA GNG12-AS1 (Silencer select, Life Technologies, S59962)70 (link) and SMARTpool siRNAs targeting protein-coding gene CKAP5/Ch-TOG (GE Dharmacon, L-006847-00) were also included on each plate. CKAP5/Ch-TOG was used as a positive control as its depletion leads to mitotic delay and increased mitotic index24 (link). ECT2 SMARTpool siRNAs (GE Dharmacon, L-006450-00-0005) were used as a positive control in the third validation screen as its depletion results in multinucleated cells26 (link).
+ Open protocol
+ Expand
5

Melanoma Cell Invasion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
WM266-4 melanoma cells were pre labeled with 2μM CellTracker Orange CMTMR dye (ThermoFischer) as per manufacturer’s protocol. RNAi screens were performed in 96 well plates to which 160 nL/well siRNA (20 μM) were plated using an Echo liquid handler (LabCyte). Prior to seeding cells, 20 μL of OptiMEM (Invitrogen) containing 160 nL/well Lipofectamine RNAiMAX (Invitrogen) was added using a Multidrop Combi Reagent Dispenser (ThermoFischer) and plates were incubated for 30 min at room temperature (RT). One day after transfection cells were seeded on top of 100 μL of 1.8 mg/mL rat-tail collagen in DMEM plus 10% heat inactivated FBS prepared as per manufacturer protocol. Collagen was pre-aliquoted into wells of a 96-well, glass-bottomed, collagen-coated plates (PerkinElmer). After 24h of incubation cells were fixed by adding 100 μL of pre-warmed 8% methanol free formaldehyde (ThermoFischer) containing 5 μg/mL Hoescht stain (Invitrogen) and incubated for 1h at RT. Cells were imaged in the OPERA QEHS (PerkinElmer), with a 20x air immersion objective. Imaging was performed at a single timepoint capturing 15 wells per field and 200-plane z-stacks. Maximum intensity projections were used for image analysis.
+ Open protocol
+ Expand
6

High-Throughput Screening Assay for CSR3

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the HTS assay, plates (10 µM compound in each well) were prepared with an Echo liquid handler (Labcyte) at the FIMM (Institute for Molecular Medicine Finland) High‐Throughput Biomedicine unit. CSR3 and annealed siRNA were diluted to 200 and 750 nM, respectively, in reaction buffer (50 mM Tris‐HCl, 125 mM NaCl, 25 mM MgCl2, pH 8.0). CSR3 solutions were dispensed into the wells of plates (10 µl CSR3 per well). Plates were incubated at room temperature for 15 min with shaking (450 rpm). Subsequently, 10 µl substrate was dispensed per well. The final CSR3 and substrate concentrations were 100 and 375 nM, respectively. The dose–response assay with six compound concentrations (range, 1.25 nM to 50 µM) was carried out with the same conditions. Plates were sealed, centrifuged briefly, and then, immediately analysed with a PHERAstar FS (BMG Labtech) with a fluorescence‐intensity optic module (excitation at 485 ± 6 nm, detection at 520 ± 5 nm) for 12 cycles (c.17 min total) at 37 °C. All dispensing was done using the BioTek MultiFlo FX. All screening plates contained positive‐control wells (lacking CSR3) and negative‐control wells (25 nl dimethyl sulphoxide, vehicle), which were used as standards to calculate the PI of compounds.
+ Open protocol
+ Expand
7

Quantitative RNA Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated using a TRI reagent. A total of 500 ng of total RNA was reverse-transcribed using a random hexamer primer and the MMLV Reverse Transcriptase Kit or 1000 ng of total RNA was reverse-transcribed using an EvoScript Universal cDNA. Quantitative PCR was carried out using the SYBR Green reagent and a LightCycler 480 apparatus (Roche, Meylan, France) or using TaqMan Gene Expression Assays and a LightCycler 1536 Instrument (Roche, Basel, Switzerland). Subsequently, 384-well plates were pipetted using Liquid Handling Robot (EpMotion 5070, Eppendorf, Hamburg, Germany), and 1536-well plates were pipetted using Echo Liquid Handler (Labcyte, Dublin, Ireland). The amplification specificity of the SYBR Green reagent was evaluated by determining the product melting curve. Target genes were determined using primers, as shown in Table 2. The relative mRNA expression was normalized to the expression of ribosomal protein lateral stalk subunit P0 (RPLP0) as a housekeeping gene. The expressions of the target genes were calculated by the ΔΔCT method [55 (link)] as fold change in the treatment groups relative to the control. All treatments were measured four times.
+ Open protocol
+ Expand
8

High-Throughput Kinase Inhibitor Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Published Kinase Inhibitor Set (PKIS) was acquired from GlaxoSmithKline by the University of Texas Southwestern High Throughput Screen facility. We modified the PKIS by adding torin1 and rapamycin into our screen. 100μl HCEC (1,000 cells/ml) cells were seeded into each wells and let adhere O/N. Half the plates received fresh media with 1% DMSO, the other half received fresh media with 300 μM BIO. Library compounds and controls were added using Echo liquid handler (Labcyte). 6 doses of each drug at 10,000 3,000, 1000, 300, 100, 30 nM were tested. Cells were then incubated for 72 hrs at 37°C and 5% CO2. Next, media was removed and 25 μl of CellTiter-Glo diluted 1:5 with passive lysis buffer (Promega) was added. Plates were incubated for 10 mins at RT with shaking and read on Envision (Perkin Elmer).
+ Open protocol
+ Expand
9

Calcium Flux Assay for M1 Muscarinic Receptor Agonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, M1-CHO cells were plated in black-walled, clear-bottomed 384-well plates (Greiner Bio-One) the day before assay. On the next day, the cells were washed with assay buffer (Hank’s balanced salt solution, 20 mM Hepes, 4.16 mM sodium bicarbonate, and 2.5 mM probenecid) and immediately incubated with 20 µl of 1.15 µM fluo-4-acetomethoxyester (Fluo-4 AM) dye solution prepared in assay buffer for 45 min at 37°C. The M1 PAMs were serially diluted (1:3) in DMSO for 10-point concentration−response curves and further diluted in assay buffer using Echo liquid handler (Labcyte). After the dye was removed, the cells were washed with assay buffer and Ca2+ flux was immediately measured using the Functional Drug Screening System (FDSS7000, Hamamatsu Photonics). The serially diluted compounds or DMSO (vehicle) was added to the cells for 2.5 min; then, an EC20 concentration of ACh was added and incubated for 2 min. An ECmax concentration of ACh was also added to cells that were incubated with DMSO to ensure the EC20 calcium response. To determine the potency and efficacy of the agonist and PAM, data were analyzed to generate a concentration-response curve using a four-point logistic equation in GraphPad Prism 5.0 (GraphPad Software Inc.).
+ Open protocol
+ Expand
10

Hedgehog Pathway Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the 384 well assay 8000 Shh-Light 2 cells per well were seeded in white 384 well plates in a total volume of 25μl DMEM high glucose containing 10% FCS, 1% glutamine and 5mM Hepes pH7.4. After culturing the cells for 24h at 37°C, compounds were added automatically by Echo Liquid Handler (Labcyte). After a further 1h incubation at 37°C 10 μl of purmorphamine with a final concentration of 1 μM were added to stimulate the hedgehog-pathway. The plates were incubated for 48h at 37°C and assayed for luciferase activity using the One Glo reporter kit (Promega). Wells containing 10 μM vismodegib were used as a positive control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!